Sleep duration, snoring habits and risk of acute myocardial infarction in China population: results of the INTERHEART study

Dongfang Xie, Wei Li, Yang Wang, Hongqiu Gu, Koon Teo, Lisheng Liu, Salim Yusuf, INTERHEART China study Investigators, Xiao-chun Chen, Guoxiong Dong, Qiang Fu, Jian Huang, Rutai Hui, Baoqi Jiang, Jianjun Li, Ximing Li, Xun Li, Yu Li, Zhanquan Li, Yuhua Liao, Xinshan Liu, Aiqun Ma, Zheng Wan, Daowen Wang, Fengzhen Wang, X Wang, Yu Wei, Tie Xu, Lin Zhang, Yanzhen Zhang, Ruiping Zhao, Changyong Zhou, Xinglei Zhu, Dongfang Xie, Wei Li, Yang Wang, Hongqiu Gu, Koon Teo, Lisheng Liu, Salim Yusuf, INTERHEART China study Investigators, Xiao-chun Chen, Guoxiong Dong, Qiang Fu, Jian Huang, Rutai Hui, Baoqi Jiang, Jianjun Li, Ximing Li, Xun Li, Yu Li, Zhanquan Li, Yuhua Liao, Xinshan Liu, Aiqun Ma, Zheng Wan, Daowen Wang, Fengzhen Wang, X Wang, Yu Wei, Tie Xu, Lin Zhang, Yanzhen Zhang, Ruiping Zhao, Changyong Zhou, Xinglei Zhu

Abstract

Background: Less sleep time and snoring have been associated with cardiovascular disease (CVD) risk in Western populations; however, few studies have evaluated the different aspects of sleep duration and snoring frequency in relation to CVD, and this association has not been examined in China. The present study aimed to address the relation between sleep duration, snoring frequency and risk of acute myocardial infarction (AMI) in China population.

Methods: We conducted a hospital-based case-control study. Cases were first AMI (n = 2909). Controls were matched to cases on age and sex. 2947 controls who did not report previous angina or physical disability completed a questionnaire on sleep duration and snoring frequency. We used logistic regression to control for other risk factors.

Results: We observed an inverse association between serious snoring frequency and AMI risk. After adjustment for all the risk factors, and the OR for everyday group and 3-5 times per week group was 1.45 (95% CI: 1.01 to 1.91) and 1.93 (95% CI: 1.52-2.46) compared to no snoring group. The OR for serious level group and moderate group was 1.77 (95% CI: 1.29 to 2.43) and 1.37 (95% CI: 1.10 to 1.69) compared to no snoring group. People having serious snoring increased 77% risk of AMI. 15.2% people in control group have ≤ 6 hours sleeping, compared with 17.4% in AMI group.

Conclusions: Snoring frequency, including as much as everyday and 3-5 times per week, was positively associated with AMI risk and less sleep duration was associated with risk of AMI. Less sleep time could increase AMI risk in China population.

Figures

Figure 1
Figure 1
Adjusted odds ratios (and 95% confidence intervals), with tests for heterogeneity for risk of acute myocardial infarction for snore frequency by different type of gender and age.

References

    1. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular disease, part I: general considerations, the epidemic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746–2753. doi: 10.1161/hc4601.099487.
    1. Sabanayagam C, Shanka A. Sleep duration and cardiovascular disease: results from the National Health Survey. Sleep. 2010;33:1037–1042.
    1. Ikehara S, Iso H, Date C, Kikuchi S, Watanabe Y, Wada Y, Inaba Y, Tamakoshi A. JACC Study Group. Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study. Sleep. 2009;32:295–301.
    1. Amagai Y, Ishikawa S, Gotoh T, Kayaba K, Nakamura Y, Kajii E. Sleep duration and incidence of cardiovascular events in a Japanese population: the Jichi Medical School cohort study. J Epidemiol. 2010;20:106–110. doi: 10.2188/jea.JE20090053.
    1. Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A, Hu FB. A prospective study of sleep duration and coronary heart disease in women. Arch Inter Med. 2003;163:205–209. doi: 10.1001/archinte.163.2.205.
    1. Qureshi A, Giles WH, Croft JB, Bliwise DL. Habitual sleep patterns and risk for stroke and coronary heart disease: a 10-year follow-up from NHANES I. Neurology. 1997;48:904–911. doi: 10.1212/WNL.48.4.904.
    1. Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol. 2005;99(5):2008–2019. doi: 10.1152/japplphysiol.00660.2005.
    1. Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence oftype 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33:414–420. doi: 10.2337/dc09-1124.
    1. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, Rundle AG, Zammit GK, Malaspina D. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension. 2006;47:833–839. doi: 10.1161/01.HYP.0000217362.34748.e0.
    1. Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: asystematic review and meta-analysis of prospective studies. Sleep. 2010;33:585–592.
    1. Gallicchio L, Kalesan B. Sleep duration and mortality: a systematic review and meta-analysis. J Sleep Res. 2009;18:148–158. doi: 10.1111/j.1365-2869.2008.00732.x.
    1. Ferrie JE, Shipley MJ, Cappuccio FP, Brunner E, Miller MA, Kumari M, Marmot MG. A prospective study of change in sleep duration: associations with mortality in the Whitehall II cohort. Sleep. 2007;30:1659–1666.
    1. Patel SR, Ayas NT, Malhotra MR, White DP, Schernhammer ES, Speizer FE, Stampfer MJ, Hu FB. A prospective study of sleep duration and mortality risk in women. Sleep. 2004;27:440–444.
    1. Knutson KL, Cauter EV, Rathouz JP, DeLeire TD, Lauderdale DS. Trends in the prevalence of short sleepers in the USA: 1975–2006. Sleep. 2010;33:37–45.
    1. Knutson KL, Spiegel K, Penev P, Van Cauter E. The metabolic consequences of sleep deprivation. Sleep. 2007;11:163–178.
    1. Gangwisch JE. Epidemiological evidence for the links between sleep, circadian rhythms and metabolism. Obes Rev. 2009;10:37–45.
    1. Koskenvuo M, Kaprio J, Partinen M, Langinvainio H, Sarna S, Heikkila K. Snoring as a risk factor for hypertension and angina pectoris. Lancet. 1985;1:893–896.
    1. Dunai A, Keszei AP, Kopp MS, Shapiro CM, Mucsi I, Novak M. Cardiovascular disease and health-careutilization in snorers: apopulationsurvey. Sleep. 2008;31:411–416.
    1. Yaggi H, Mohsenin V. Obstructive sleep apnoea and stroke. Lancet Neurol. 2004;3:333–342. doi: 10.1016/S1474-4422(04)00766-5.
    1. Hu FB, Willett WC, Manson JE, Colditz GA, Rimm EB, Speizer FE, Hennekens CH, Stampfer MJ. Snoring and risk of cardiovascular disease in women. J Am Coll Cardiol. 2000;35:3081–3083.
    1. Koskenvuo M, Kaprio J, Telakivi T, Partinen M, Heikkila K, Sarna S. Snoring as a risk factor for ischaemic heart disease and stroke in men. Br Med J (Clin Res Ed) 1987;294:169.
    1. Erlichman J, Kerbey AL, James WP. Physical activity and its impact on health out-comes. Paper 1: The impact of physical activity on cardiovascular disease and all-cause mortality: an historical perspective. Obes Rev. 2002;3:257–271. doi: 10.1046/j.1467-789X.2002.00077.x.
    1. Hu G, Tuomilehto J, Silventoinen K, Barengo NC, Peltonen M, Jousilahti P. The effects of physical activity and body mass index on cardiovascular, cancer and all-cause mortality among 47 212 middle-aged Finnish men and women. Int J Obes (Lond) 2005;29:894–902. doi: 10.1038/sj.ijo.0802870.
    1. Katzmarzyk PT, Janssen I, Ardern CI. Physical inactivity, excess adiposity and pre-mature mortality. Obes Rev. 2003;4:257–290. doi: 10.1046/j.1467-789X.2003.00120.x.
    1. Franklin KA. Cerebral haemo dynamics in obstructive sleep apnoea and Cheyne-Stokes respiration. Sleep Med Rev. 2002;6:429–441. doi: 10.1053/smrv.2001.0206.
    1. Bokinsky G, Miller M, Ault K, Husband P, Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasalcontinuouspositiveairwaypressure. Apreliminary investigation. Chest. 1995;108:625–630. doi: 10.1378/chest.108.3.625.
    1. Wessendorf TE, Thilmann AF, Wang YM, Schreiber A, Konietzko N, Teschler H. Fibrinogen level sand obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med. 2000;162:2039–2042. doi: 10.1164/ajrccm.162.6.2001048.
    1. Narkiewicz K, vande Borne PJ, Montano N, Dyken ME, Phillips BG, Somers VK. Contribution of to nicchemoreexfl activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation. 1998;97:943–945. doi: 10.1161/01.CIR.97.10.943.
    1. Nonogaki K. New insights into sympathetic regulation of glucose and fatmetabolism. Diabetologia. 2000;43:533–549. doi: 10.1007/s001250051341.
    1. Ciftci TU, Kokturk O, Bukan N, Bilgihan A. The relation ship between serumcy to kine levels with obesity and obstructive sleep apnea syndrome. Cytokine. 2004;28:87–91. doi: 10.1016/j.cyto.2004.07.003.
    1. Follenius M, Brandenberger G, Bandesapt JJ, Libert JP, Ehrhart J. Nocturnal cortisol release in relation to sleep structure. Sleep. 1992;15:217.
    1. Stamatakis KA, Punjabi NM. Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest. 2010;137:95–101. doi: 10.1378/chest.09-0791.
    1. Atkeson A, Jelic S. Mechanisms of endothelialdys function in obstructive sleep apnea. Vasc Health Risk Manag. 2008;4:1327–1335.
    1. Gottlieb DJ, Yenokyan G, Newman AB, OConnor GT, Punjabi NM, Quan SF, O’Connor GT, Punjabi NM, Quan SF, Redline S, Resnick HE, Tong EK, Diener-West M, Shahar E. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the Sleep Heart Health Study. Circulation. 2010;122:352–360. doi: 10.1161/CIRCULATIONAHA.109.901801.
    1. Goldstein C, Zee PC. Obstructive sleep apnea-hypopnea and incident stroke: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2010;182:269–277. doi: 10.1164/rccm.200911-1746OC.
    1. Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S. PURE Investigators-Writing Group. The Prospective Urban Rural Epidemiology (PURE) study: Examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J. 2009;158:1–7. doi: 10.1016/j.ahj.2009.04.019.
    1. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet. 2004;364:937–952. doi: 10.1016/S0140-6736(04)17018-9.
    1. Iqbal R, Anand S, Ounpuu S, Islam S, Zhang X, Rangarajan S, Chifamba J, Al-Hinai A, Keltai M, Yusuf S. INTERHEART Study Investigators. Dietary patterns and the risk of acute myocardial infarction in 52 Countries: results of the INTERHEART Study. Circulation. 2008;118:1929–1937. doi: 10.1161/CIRCULATIONAHA.107.738716.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel